Files and links (1)
Published, Version of Record (VoR)CC BY V4.0, Open
Journal article
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
Frontiers in immunology, Vol.11, pp.1880-1880
19 Aug 2020
PMID: 32973779
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome infecting animals and humans. Coronaviruses have been described more than 70 years ago and contain many species. Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are lethal species caused by human coronaviruses (HCoVs). Currently, a novel strain of HCoVs, named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (Covid-19). SARS-CoV-2 was first identified in December 2019 in Wuhan, the capital city of the Hubei province of China, and has since spread worldwide causing an outbreak in more than 200 countries. The SARS-CoV-2 outbreak was declared a pandemic on March 11th, 2020 and a public health emergency of international concern (PHEIC) in late January 2020 by the World Health Organization (WHO). SARS-CoV-2 infects the respiratory tract causing flu-like symptoms and, in some, may cause severe illness like pneumonia and multi-organ failure leading to death. Today, Covid-19 cases almost reaching 9 million, with more than 450 thousand deaths. There is an urgent demand for developing a vaccine since no effective therapies or vaccines have been approved to this day to prevent or minimize the spread of the infection. In this review, we summarized the furthest vaccines in the clinical pipeline.
Metrics
2 Record Views
Details
- Title
- The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
- Creators
- Sana O. Alturki - Drexel UniversitySawsan O. Alturki - Drexel UniversityJennifer Connors - Drexel UniversityGina Cusimano - Drexel UniversityMichele A. Kutzler - Drexel UniversityAbdullah M. Izmirly - Drexel UniversityElias K. Haddad - Drexel University
- Publication Details
- Frontiers in immunology, Vol.11, pp.1880-1880
- Publisher
- Frontiers Media S.A
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Infectious Diseases (and HIV Medicine); Microbiology and Immunology
- Identifiers
- 991019167933704721
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Immunology